Skip to main content

Table 6 Prevalence, prevalence difference and prevalence ratios (95% confidence intervals) of health services utilization in the last three months and of preventive activities in the last year by per capita income according to SGSSS insurance scheme and private health plan, in the study areas of Colombia and Brazil (2011)

From: Inequities in access to health care in different health systems: a study in municipalities of central Colombia and north-eastern Brazil

 

Colombia

Brazil

 

Contributory scheme

Subsidized scheme

Without private health plan

With private health plan

 

n

Prev

PD

PR (CI 95%)a

n

Prev

PD

PR (CI 95%)a

n

Prev

PD

PR (CI 95%)a

n

Prev

PD

PR (CI 95%)a

Primary care

                

  < 1/2 MW

261

57.9

 

1

210

51.0

 

1

506

49.3

 

1

44

46.8

 

1

  1/2 - 1 MW

243

58.0

0.1

1.05 (0.94 - 1.17)

70

54.7

3.7

1.08 (0.90 - 1.29)

247

45.2

-4.1

0.91 (0.81 - 1.02)

63

36.4

-10.4

0.75 (0.56 - 1.02)

  > 1 MW

214

58.0

0.1

1.03 (0.92 - 1.16)

18

56.3

5.3

1.07 (0.78 - 1.48)

47

32.0

-17.3

0.69 (0.54 - 0.88)

51

30.5

-16.3

0.66 (0.48 - 0.93)

Outpatient secondary care

                

  < 1/2 MW

105

23.3

 

1

65

15.8

 

1

212

20.6

 

1

16

17.0

 

1

  1/2 - 1 MW

89

21.2

-2.1

1.02 (0.80 - 1.29)

19

14.8

-1.0

0.87 (0.55 - 1.39)

141

25.8

5.2

1.17 (0.98 - 1.41)

59

34.1

17.1

1.94 (1.22 - 3.10)

  > 1 MW

106

28.7

5.4

1.26 (1.01 - 1.58)

9

28.1

12.3

1.72 (0.98 - 3.02)

38

25.9

5.3

1.34 (1.00 - 1.79)

58

34.7

17.7

1.98 (1.23 - 3.20)

Emergency care

                

  < 1/2 MW

87

19.3

 

1

91

22.1

 

1

348

33.9

 

1

42

44.7

 

1

  1/2 - 1 MW

84

20.1

0.8

1.11 (0.85 - 1.45)

28

21.9

-0.2

1.19 (0.82 - 1.73)

194

35.5

1.6

1.19 (1.04 - 1.38)

46

26.6

-18.1

0.63 (0.45 - 0.87)

  > 1 MW

59

16.0

-3.3

0.95 (0.70 - 1.29)

4

12.5

-9.6

0.72 (0.29 - 1.75)

37

25.2

-8.7

0.90 (0.67 - 1.22)

37

22.2

-22.5

0.70 (0.48 - 1.01)

Glycemic control (adults)

                

  < 1/2 MW

230

58.4

 

1

152

46.9

 

1

391

52.1

 

1

36

58.1

 

1

  1/2 - 1 MW

188

50.4

-8.0

0.93 (0.82 - 1.05)

57

50.0

3.1

1.07 (0.87 - 1.31)

268

57.0

4.9

1.11 (1.00 - 1.23)

78

66.1

8.0

1.15 (0.90 - 1.47)

  > 1 MW

208

61.4

3.0

1.11 (0.99 - 1.25)

14

48.3

1.4

1.03 (0.71 - 1.51)

67

50.0

-2.1

1.05 (0.87 - 1.26)

93

67.4

9.3

1.21 (0.95 - 1.53)

Caries prevention (adults)

                

  < 1/2 MW

149

37.8

 

1

108

33.3

 

1

107

14.3

 

1

16

25.8

 

1

  1/2 - 1 MW

149

40.0

2.2

1.02 (0.85 - 1.22)

51

44.7

11.4

1.45 (1.12 - 1.87)

88

18.7

4.4

1.37 (1.06 - 1.76)

41

34.8

9.0

1.34 (0.83 - 2.17)

  > 1 MW

139

41.0

3.2

1.06 (0.88 - 1.27)

13

44.8

11.5

1.45 (0.97 - 2.16)

23

17.2

2.9

1.11 (0.73 - 1.69)

58

42.0

16.2

1.87 (1.16 - 3.01)

Breast cancer prevention (women)

              

  < 1/2 MW

88

31.3

 

1

32

12.8

 

1

149

25.3

 

1

19

38.0

 

1

  1/2 - 1 MW

86

33.6

2.3

1.13 (0.89 - 1.42)

25

31.3

18.5

2.00 (1.28 - 3.11)

100

27.4

2.1

1.20 (0.97 - 1.47)

28

29.8

-8.2

0.77 (0.48 - 1.23)

  > 1 MW

87

40.5

9.2

1.35 (1.07 - 1.69)

6

26.1

13.3

1.69 (0.82 - 3.45)

27

31.0

5.7

1.50 (1.05 - 2.14)

42

42.9

4.9

1.10 (0.73 - 1.68)

  1. Prev, Prevalence; PD, Prevalence Difference; PR, Prevalence ratio; CI, Confidence Interval; MW, minimum wage.
  2. aPrevalence Ratio and 95% confidence interval adjusted for sex, age, race/color, chronic condition, self-rated health status.
  3. Statistically significant results are shown in bold.